New
On March 21, 2024, French health authorities granted special permission for doctors to prescribe Protopic 0.1% (Tacrolimus) for treating vitiligo in adults and children over 2 years old. This kind of permission is given when there's already a different approved treatment available, but this ointment might better meet some patients' needs.
Companies Pierre Fabre Médicament and Léo Pharma A/S that make this ointment must follow certain rules for using it and keeping track of how it's working. This includes regular updates to a health monitoring center in Toulouse and providing summaries of how the treatment is going.
This special permission is set for three years from the day after the decision was announced on the ANSM website. The director general of the health authority, Christelle Ratignier-Carbonneil, signed off on this decision.
FAQOther Questions
- I have a new job - should I tell colleagues about my vitiligo?
If you are starting a new job and you are concerned about stares and questions about your skin, try a proactive approach. When the time is right and you are feeling comfortable,...
- How long does it take to treat vitiligo?
Vitiligo, a condition characterized by the loss of skin pigment, can be unpredictable in both progression and treatment. The time it takes to treat vitiligo varies significantly...
- Can Ayurveda help with vitiligo?
People have used herbs and natural remedies to treat skin conditions for centuries. Vitiligo is an auto-immune condition that causes white patches of skin to develop and expand...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.